333 related articles for article (PubMed ID: 29871821)
1. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
Ametsbichler P; Böhlandt A; Nowak D; Schierl R
Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
[TBL] [Abstract][Full Text] [Related]
2. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination.
Ndaw S; Hanser O; Kenepekian V; Vidal M; Melczer M; Remy A; Robert A; Bakrin N
Toxicol Lett; 2018 Dec; 298():171-176. PubMed ID: 29852276
[TBL] [Abstract][Full Text] [Related]
3. Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).
Schierl R; Novotna J; Piso P; Böhlandt A; Nowak D
Eur J Surg Oncol; 2012 Jan; 38(1):88-94. PubMed ID: 22035874
[TBL] [Abstract][Full Text] [Related]
4. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
[TBL] [Abstract][Full Text] [Related]
5. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow.
Delhorme JB; Klipfel A; D'Antonio F; Greget MC; Diemunsch P; Rohr S; Romain B; Brigand C
J Visc Surg; 2019 Dec; 156(6):485-488. PubMed ID: 31296454
[TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
Robella M; Vaira M; De Simone M
World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin and oxaliplatin surface contamination in intensive care units (ICUs) and hospital wards during attendance of HIPEC patients.
Schenk KE; Schierl R; Angele M; Burkhart-Reichl A; Glockzin G; Novotny A; Nowak D
Int Arch Occup Environ Health; 2016 Aug; 89(6):991-6. PubMed ID: 27142971
[TBL] [Abstract][Full Text] [Related]
8. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.
Larroque M; Arnaudguilhem C; Bouyssiere B; Quenet F; Bouazza N; Jarlier M; Boulabas S; Mounicou S; Sgarbura O
Toxicol Appl Pharmacol; 2021 Oct; 429():115694. PubMed ID: 34428445
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
11. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.
Solass W; Giger-Pabst U; Zieren J; Reymond MA
Ann Surg Oncol; 2013 Oct; 20(11):3504-11. PubMed ID: 23765417
[TBL] [Abstract][Full Text] [Related]
12. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
[TBL] [Abstract][Full Text] [Related]
13. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
[TBL] [Abstract][Full Text] [Related]
14. Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects.
Hübner M; Grass F; Teixeira-Farinha H; Pache B; Mathevet P; Demartines N
Eur J Surg Oncol; 2017 Jun; 43(6):1102-1109. PubMed ID: 28431896
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure.
Konate A; Poupon J; Villa A; Garnier R; Hasni-Pichard H; Mezzaroba D; Fernandez G; Pocard M
J Surg Oncol; 2011 Jan; 103(1):6-9. PubMed ID: 20886552
[TBL] [Abstract][Full Text] [Related]
17. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.
Demtröder C; Solass W; Zieren J; Strumberg D; Giger-Pabst U; Reymond MA
Colorectal Dis; 2016 Apr; 18(4):364-71. PubMed ID: 26400556
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
[TBL] [Abstract][Full Text] [Related]
19. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience.
Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA
Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155
[TBL] [Abstract][Full Text] [Related]
20. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study.
Tavernier C; Passot G; Vassal O; Allaouchiche B; Decullier E; Bakrin N; Alyami M; Davigo A; Bonnet JM; Louzier V; Paquet C; Glehen O; Kepenekian V
Surg Endosc; 2020 Jul; 34(7):2939-2946. PubMed ID: 31456025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
